Dexcom Inc Stock Technical Analysis
| DXCM Stock | USD 72.27 0.53 0.73% |
As of the 19th of February, DexCom shows the Coefficient Of Variation of 633.7, mean deviation of 1.4, and Downside Deviation of 1.71. DexCom Inc technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm DexCom Inc jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if DexCom Inc is priced favorably, providing market reflects its regular price of 72.27 per share. Given that DexCom has jensen alpha of 0.2581, we urge you to verify DexCom Inc's prevailing market performance to make sure the company can sustain itself at a future point.
DexCom Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as DexCom, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DexComDexCom's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.DexCom Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 85.46 | Strong Buy | 26 | Odds |
Most DexCom analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand DexCom stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of DexCom Inc, talking to its executives and customers, or listening to DexCom conference calls.
Will Health Care Equipment & Supplies sector continue expanding? Could DexCom diversify its offerings? Factors like these will boost the valuation of DexCom. Projected growth potential of DexCom fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DexCom data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.78 | Earnings Share 2.07 | Revenue Per Share | Quarterly Revenue Growth 0.131 | Return On Assets |
Understanding DexCom Inc requires distinguishing between market price and book value, where the latter reflects DexCom's accounting equity. The concept of intrinsic value - what DexCom's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push DexCom's price substantially above or below its fundamental value.
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
DexCom 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DexCom's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DexCom.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in DexCom on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding DexCom Inc or generate 0.0% return on investment in DexCom over 90 days. DexCom is related to or competes with STERIS Plc, Insulet, Zimmer Biomet, Koninklijke Philips, Smith Nephew, Laboratory, and Waters. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ... More
DexCom Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DexCom's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DexCom Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.71 | |||
| Information Ratio | 0.1252 | |||
| Maximum Drawdown | 9.82 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 3.31 |
DexCom Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DexCom's standard deviation. In reality, there are many statistical measures that can use DexCom historical prices to predict the future DexCom's volatility.| Risk Adjusted Performance | 0.127 | |||
| Jensen Alpha | 0.2581 | |||
| Total Risk Alpha | 0.1616 | |||
| Sortino Ratio | 0.1426 | |||
| Treynor Ratio | 0.4007 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DexCom February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.127 | |||
| Market Risk Adjusted Performance | 0.4107 | |||
| Mean Deviation | 1.4 | |||
| Semi Deviation | 1.35 | |||
| Downside Deviation | 1.71 | |||
| Coefficient Of Variation | 633.7 | |||
| Standard Deviation | 1.95 | |||
| Variance | 3.81 | |||
| Information Ratio | 0.1252 | |||
| Jensen Alpha | 0.2581 | |||
| Total Risk Alpha | 0.1616 | |||
| Sortino Ratio | 0.1426 | |||
| Treynor Ratio | 0.4007 | |||
| Maximum Drawdown | 9.82 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 3.31 | |||
| Downside Variance | 2.94 | |||
| Semi Variance | 1.82 | |||
| Expected Short fall | (1.50) | |||
| Skewness | 0.8121 | |||
| Kurtosis | 2.52 |
DexCom Inc Backtested Returns
DexCom appears to be very steady, given 3 months investment horizon. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.17, which denotes the company had a 0.17 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please utilize DexCom's Coefficient Of Variation of 633.7, downside deviation of 1.71, and Mean Deviation of 1.4 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DexCom holds a performance score of 13. The firm shows a Beta (market volatility) of 0.74, which means possible diversification benefits within a given portfolio. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. Please check DexCom's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether DexCom's price patterns will revert.
Auto-correlation | 0.35 |
Below average predictability
DexCom Inc has below average predictability. Overlapping area represents the amount of predictability between DexCom time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom Inc price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current DexCom price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 4.75 |
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
DexCom Inc Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of DexCom Inc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About DexCom Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of DexCom Inc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of DexCom Inc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on DexCom Inc price pattern first instead of the macroeconomic environment surrounding DexCom Inc. By analyzing DexCom's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of DexCom's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to DexCom specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 4.82 | 4.62 | 5.4 | 9.44 | Days Of Inventory On Hand | 153.18 | 124.18 | 123.45 | 69.89 |
DexCom February 19, 2026 Technical Indicators
Most technical analysis of DexCom help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for DexCom from various momentum indicators to cycle indicators. When you analyze DexCom charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.127 | |||
| Market Risk Adjusted Performance | 0.4107 | |||
| Mean Deviation | 1.4 | |||
| Semi Deviation | 1.35 | |||
| Downside Deviation | 1.71 | |||
| Coefficient Of Variation | 633.7 | |||
| Standard Deviation | 1.95 | |||
| Variance | 3.81 | |||
| Information Ratio | 0.1252 | |||
| Jensen Alpha | 0.2581 | |||
| Total Risk Alpha | 0.1616 | |||
| Sortino Ratio | 0.1426 | |||
| Treynor Ratio | 0.4007 | |||
| Maximum Drawdown | 9.82 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 3.31 | |||
| Downside Variance | 2.94 | |||
| Semi Variance | 1.82 | |||
| Expected Short fall | (1.50) | |||
| Skewness | 0.8121 | |||
| Kurtosis | 2.52 |
DexCom February 19, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as DexCom stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 75,377 | ||
| Daily Balance Of Power | (0.32) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 72.44 | ||
| Day Typical Price | 72.38 | ||
| Price Action Indicator | (0.43) |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Health Care Equipment & Supplies sector continue expanding? Could DexCom diversify its offerings? Factors like these will boost the valuation of DexCom. Projected growth potential of DexCom fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DexCom data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.78 | Earnings Share 2.07 | Revenue Per Share | Quarterly Revenue Growth 0.131 | Return On Assets |
Understanding DexCom Inc requires distinguishing between market price and book value, where the latter reflects DexCom's accounting equity. The concept of intrinsic value - what DexCom's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push DexCom's price substantially above or below its fundamental value.
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.